These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27235611)

  • 1. Pharmacologic Therapies in Anticoagulation.
    Ferreira JL; Wipf JE
    Med Clin North Am; 2016 Jul; 100(4):695-718. PubMed ID: 27235611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists?
    Guay DR
    Hosp Pract (1995); 2011 Feb; 39(1):105-25. PubMed ID: 21441766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral anticoagulants: their role in stroke prevention in high-risk patients with atrial fibrillation.
    Ferns SJ; Naccarelli GV
    Med Clin North Am; 2015 Jul; 99(4):759-80. PubMed ID: 26042881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-specific oral anticoagulants: practice issues for the clinician.
    Plitt A; Giugliano RP
    Hosp Pract (1995); 2014 Aug; 42(3):48-61. PubMed ID: 25255406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
    Kampouraki E; Kamali F
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new era of anticoagulation.
    Skeik N; Rumery KK; Rodriguez GT
    Ann Vasc Surg; 2014 Feb; 28(2):503-14. PubMed ID: 24412298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
    Verheugt FW; Granger CB
    Lancet; 2015 Jul; 386(9990):303-10. PubMed ID: 25777666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional and new oral anticoagulants in the treatment of chest disease and its complications.
    Gallego P; Roldan V; Lip GY
    Am J Respir Crit Care Med; 2013 Aug; 188(4):413-21. PubMed ID: 23672179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence.
    Hajra A; Ujjawal A; Ghalib N; Chowdhury S; Biswas S; Balasubramanian P; Gupta R; Aronow WS
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102017. PubMed ID: 37544618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Blanco-Molina A
    Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants in patients with cancer.
    Bossaer JB; Covert KL
    Am J Health Syst Pharm; 2019 Jul; 76(14):1019-1027. PubMed ID: 31361880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management.
    Mookadam M; Shamoun FE; Ramakrishna H; Obeid H; Rife RL; Mookadam F
    Ann Card Anaesth; 2015; 18(4):517-27. PubMed ID: 26440238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].
    Gulizia Chairperson MM; Parrini Co-Chairperson I; Colivicchi Co-Chairperson F; Bisceglia I; Caiazza F; Gensini GF; Mureddu GF; Santomauro M; Ageno W; Ambrosetti M; Aspromonte N; Barni S; Bellocci F; Caldarola P; Carletti M; De Luca L; Di Fusco SA; Di Lenarda A; Di Nisio M; Domenicucci S; Enea I; Francese GM; Lestuzzi C; Lucà F; Maurea N; Nassiacos D; Pedretti RFE; Pusineri E; Roscio G; Rossini R; Russo A; Volterrani M; Gabrielli Co-Chairperson D
    G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current and future role of the novel oral anticoagulants--indications beyond atrial fibrillation.
    Lee A; Rajaratnam R
    Heart Lung Circ; 2014 Jan; 23(1):2-9. PubMed ID: 24183214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.